GALNT7 and colorectal cancer: Notably, despite the relatively smaller sample size of MSI colorectal cancers, GALNT7 expression was significantly associated with survival outcomes across all MSI cohorts, including TCGA MSI (n = 73; log-rank P = 0.0443; Cox HR = 0.23; 95% CI, 0.04–0.93; Fig. 2A), AC-ICAM MSI (n = 57; P = 0.0034; HR = 0.14; 95% CI, 0.02–0.54; Fig. 2B), and GSE39582 MSI (n = 71; P = 0.0112; HR = 0.11; 95% CI, 0.01–0.59; Fig. 2C).